Buffett and Berkshire Hathaway have decided to add to their stake in DaVita once again. This company is one of the largest in the kidney care business throughout the United States of America, and it is currently expanding in other parts of the world. According to the SEC, Berkshire Hathaway and Warren Buffett have added to their DVA stock right after the earnings report release earlier last week.
As a matter of fact, the Securities and Exchange Commission documents tell us that Berkshire Hathaway has purchased another 3.7 million shares. The company stake in this firm is now around 16 ½%.
In total, Berkshire and Warren Buffett now have 35.1 million shares in the kidney care company. At the time of this writing, the business operates around 2000 dialysis clinics in total. Buffett and Berkshire have agreed to limit their share of DVA stock to 25% without the company’s consent.
This past August, the dialysis company announced a 2-for-1 stock split that was effective in late September. The move increased the number of outstanding shares to over 212 million. Buffett and Berkshire have now been purchasing stock for the last two years.
This past Monday morning, DVA shares gained about 2% in trading. Year to date, the stock is only up 3%, and thanks to the stock split it’s only up over 1% in the last 12 months.